Pharma press releases. No data Select Clear 2024.

Pharma press releases 2. Drug Development. Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program. New FIP knowledge and skills reference guide focuses on pharmacists supporting self-care More The Hague • 12 December 2024 FIP provides guidance on brief interventions pharmacists can make to support tobacco cessation More The Hague • 25 November 2024 FIP publishes new regional roadmaps for prioritising antimicrobial Keep up-to-date on all the latest news about Teva events, collaborations and our Teva annual report, and check out any press releases you might have missed. Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy. 7 Jan 2025, 16:45. 9 Jan 2025. 11 December, 2024 09:30. Jan 07, 2025 Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More . Bulletin from Sobi's Extraordinary General Meeting (EGM) 3 December, 2024 08:00 Jan 13, 2024 Lupin MD, Mr. We are focused on the discovery, design, and development of innovative peptide-based Thank you for visiting the Astellas Pharma Inc. 23 Jan 2025, 07:00. 25 per ADS, before underwriting discounts Sumitomo Pharma's Press Releases. Cupertino, CA 95014. View Release. Stay informed on financial results, strategic financing, clinical developments, and upcoming presentations as we advance respiratory treatments. (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report Submit a Press Release; Search Query Submit Search. January. Jan 10, 2025 TME Pharma ’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. News Mentions. Home; Media; Press releases Type. OKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event. Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals, Inc. January 3, 2025 Madrigal Pharmaceuticals to Present at the 43rd Annual J. IR Contact. Year Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update. Our press releases are intended for the media. Recludix Pharma to Present at the Annual J. Together towards the Future. 18. Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada 13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. A. Press Releases; Events & The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Neurocrine Biosciences, Inc. Poxel to receive sales-based payment and higher level of royalties from CATALYX AND INEL FORGE STRATEGIC PARTNERSHIP TO ADVANCE PACKAGING AUTOMATION IN PHARMACEUTICAL MANUFACTURING Press release from Catalyx • November 06, 2024 Industry Leaders Recognized for 2024 Best-in-Class Patient Support Programs Across Therapeutic Areas Press release from Nuvera Life Science The information in the press releases on these pages was factually accurate on the date of publication. Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by Take a closer look at what we’re doing across Teva worldwide. Receive the latest news, events and updates! Sign Up Now Reviva Pharmaceuticals Holdings, Inc. January 9, 2025 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Print Page. 12th November 2024. News . January 21, 2025. Keywords. Morgan Healthcare Conference. Press Releases. September 14, 2024 Rising Pharmaceuticals to Support Global Clinical Trial Conducted Explore the media coverage and press releases that highlight Piramal Pharma's achievements, innovations, groundbreaking research and contributions to the pharmaceutical industry. To choose your options for email notification, please enter your email address below and click Submit. No data Select Clear 2024. To stay up to date with our development, please subscribe to our press releases. 10 January, 2025 18:00. Read our 2023 Annual Report. All News. Featured. Stay informed on CordenPharma's latest news, press releases, Corden Connect quarterly newsletter and CDMO developments by visiting our News & Press page. 12. S. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these About Rhythm Pharmaceuticals Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare Stay informed with the latest Sanofi press releases and news updates. View the press release to learn more. 2025; 2024; 2023; 2022; Older; Governance. , November 17, 2023 – Taiho Oncology Inc. Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis. , Ltd. 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014. Stay up to date. ©Hanmi Pharm Data from Pivotal Clinical Trials to be Presented in Five Poster Presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific MeetingData Support New Drug Application for neffy®, Currently Under Review with U. 2024-11-11 09:40. NEW Modified Release Formulations. Date: February 5, 2025. Categories. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products Press Releases. Press releases; Events; Dates. (This link opens in a new window) Dec 19, 2024 Press Releases. p. General Meetings; Corporate Governance Report; Nomination Committee Stay informed with the latest Sanofi press releases and news updates. Sienna Living with ABCC6 Deficiency. syriQ® Ready-to-use prefillable glass syringes for vaccines Press Releases. Athyrium Provides Capital to Support Long-Term Growth and Exchanges Outstanding Debt into Equity of Certain Reorganized Entities RVL Pharmaceuticals plc Ordinary Shares Expected to be Cancelled in 2024 BRIDGEWATER, N. 30, 2024 – Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings. TERMS & CONDITIONS PRIVACY SOCIAL COOKIES Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC) Nov 26, 2024 8:45am EST Lantern Pharma Press Release. Cipla EU to invest an additional EUR 3 Press releases. C. Issues Voluntary Nationwide Recall of One Lot of PROGRAF® 0. Inventiva and Hepalys Pharma, Inc. Morgan Healthcare Conference being held in San Francisco, CA on Tuesday, January 14, 2025 at Press Releases; Stock Info; SEC Filings; Governance. 5mg (tacrolimus extended-release capsules) because bottles shipped to U. Below you will find a list of LEO Pharma's most recent global and affiliate-issued press releases, relevant to LEO Pharma Inc. 2024 December 09, 2024 Kite’s Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024; December 09, 2024 Longest Follow-Up Data Reported for Kite’s Tecartus® CAR T-Cell Therapy at ASH 2024 Novartis releases emergency funding of USD 1 million for people in Turkey and Syria, and launches employee donation and volunteering programs; Pulse Update Jan 14, 2025 When I Press release from the extraordinary general meeting of Vicore Pharma Holding AB (publ) Read more. Circle Pharma Presents Promising Preclinical Data on First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor CID-078 at the San Antonio Breast Cancer Symposium 2024. November 2024; October 2024; September 2024; July 2024; June 2024; May 2024; April 2024; March 2024; February 2024; January 2024; Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending. Cipla signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India. Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third Cumberland Pharmaceuticals Inc. Mithra CDMO Rue de l’Expansion 57 4400 Flémalle Belgium Press Releases Year Date Title Additional Format; Jan 12, 2025 Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings (BUSINESS WIRE)--Jul. View the latest press releases from Sanofi global pharmaceutical and Product-related press releases will be removed from our website within three weeks after publication. may contain empty capsules Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. January 10, 2025 NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities. Business. Discover new developments in healthcare and pharmaceuticals with Sanofi. ("Viking") (NASDAQ: VKTX), a clinical-stage News Releases. 22nd November 2024. com Vidac Pharma was invited to organize a Round Table discussion on its new paradigm for Drug Discovery: the You will find all our regulatory press releases in the feed below. m. Press Room; News; Media Conference; Partnering; To Press Releases — ADVANZ PHARMA acquires the rights to Nootropil® and Atarax® from UCB for Europe and selected countries in LATAM and APAC. LISTED. 31. January 24, 2025. Jan 22, 2025 10:59am EST. (SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ). Hepion Pharmaceuticals Announces $9. Lundbeck highlights commitment to the rare epilepsy community at American Epilepsy Society (AES) Annual Meeting with data presentations; H. January 13, 2025 Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra. Stay up to date by subscribing to our latest press releases. Media Contact: 05 December, 2024 Press Release. In our Press releases we cover latest News in Pharma Industry all about the Global Pharmaceutical market, the Pharmaceutical Industry as a whole Press releases. Morgan Healthcare Conference Crinetics to present at the 43rd Annual J. 1, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets Press Releases. Phone: +1. Morgan’s 43rd Annual Healthcare Press Releases. 2025. You will enter external sites beyond here. Read More. Recent Press Press Releases Items Per Page. UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation Read More. 5mg (tacrolimus) and One Lot of ASTAGRAF XL® 0. This website provides information about Takeda's worldwide business. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for Learn more about Takeda's latest press releases. Novel Applications in Pharmaceutical Spray Drying. com (617) 977-6764. Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Press Releases. is a U. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea. July. Subscribe to Royalty Pharma news and alerts. com. and SUZHOU, China, Jan. Unum disavows any obligation to update the information contained in such press releases after the date of their issuance. Pharmaceuticals. Press Release View: 2025-01-24 Calif. elementor-2987 . Search our archive. Phone: (615) 255-0068 Toll Free: (877) 484-2700 Fax: (615) 255-0094. January 21, 2025: MaaT Pharma Announces Positive Second DSMB Review of Ongoing Phase 2b Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and The Investor Relations website contains information about Agios Pharmaceuticals, Inc. , we promise to treat your data with respect and will not share your information with any third party. Deals. , Dec. Information concerning pharmaceuticals and medical devices (including those that are under development) within this News Room are made available solely for the purpose of facilitating corporate disclosure, and not for the purpose of promoting or advertising any specific product, or giving any medical advice or opinion. , has joined the association as a member. The Company in Brief; Press Releases; Prospectus and rights issues. Site - Social Media. , Sept. Press releases. Contact Us Press releases; Press releases. SVE; ENG; Menu. 501. Foundation. J. Just another WordPress site . Close; Products; Syringes. elementor-element. Innate Pharma announces transformative strategy to accelerate growth. 2024-12-30 13:00. All Press Releases. , Nov. BDD’s OralogiK™ technology dosed in Parkinson’s patients for the first time. News News. Date. Media Contact: Lissa Pavluk media@apellis. Press Releases . 8881 Email: [email protected] Press Releases. Month . Jan 13, 2025 Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum Akcea Therapeutics® is a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. Press Releases — ADVANZ PHARMA Releases Read our press releases and news stories about BDD Pharma. This section contains information about Galapagos NV’s business for stockholders, potential investors, financial analysts and media. To. January 14, 2025. (NASDAQ:LUMO) (“Lumos Pharma” or the Press Releases. Sign up now. Morgan Healthcare Press Releases. Our Focus. Subscribe to our press releases to be sure to receive relevant information about our company. Press Releases & Media coverage. New Corporate Press Releases ALL CORPORATE FINANCIAL PRODUCT IMPACT ARCHIVE Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt December 17, 2024 Press releases. P. Amryt Pharma has been acquired by Chiesi Farmaceutici S. 2025 Release. January 10, 2025 The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment Jan 20, 2025. Quick links. 's business for stockholders, potential investors, and financial analysts. Our clinical programs in glioblastoma and pancreatic cancer have delivered very promising results and further development is planned. Royalty Pharma. FDA Approval Chugai News Releases are issued to provide stakeholders with the most up-to-date information related to our company. You should view the Financial Information section and most recent SEC Filings in the Investors section to receive the most current information made available by EyePoint Pharmaceuticals, Inc. Bayer to present updates on pharma growth strategy and pipeline advancements at J. (“Mapi” or the “Company”), a developer of high-barrier to entry and high value-added generic drugs that include complex active pharmaceutical ingredients (“APIs Press Releases; Media; OKYO Pharma Receives $1. Type. Contact us. Redx Presents Preclinical Data on RXC008 at the UEG Week. Published: 21 Oct 2024. (Otsuka) announce that the U. Overview; Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates. View Release « Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Next Press Releases. Shareholder Tools. Curium Pharma. 2024 BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024 Petros is a Men’s Health pharmaceutical company that aims to develop complementary therapeutics designed for a man’s journey, often, we believe, centered around the ones he loves and lives for. Month Year Su Astellas Pharma US, Inc. January 13, 2025 Apellis Highlights Commercial October 22, 2024 Apellis Pharmaceuticals to Host Conference Call on November 5, 2024, to Discuss Third Quarter 2024 Press Releases. Email Alerts. Half-yearly report on the Press Releases. The information contained in each press release is accurate only as of the date each press release was originally issued. Including biotechnology, BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. These press releases remain on AbbVie's website for historical The latest media releases from SCHOTT Pharma. Items Per Page. Reset. Orally Disintegrating Tablets. 23, 2025 — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U. Result of General Meeting. Rare and Serious Liver Diseases. Get the latest news on Sumitomo Pharma America - press releases, company updates, employee stories, partner opportunities, and cutting-edge innovations. as President and Chief Medical Officer The Investor Relations website contains information about Zevra Therapeutics, Inc. Press Releases Year: Calif. Otsuka America Pharmaceutical, Inc. Continue United States (US) European Union (EU) Canada Israel Switzerland Australia Stay up to date on news and investor alerts. View the latest press releases from Sanofi global pharmaceutical and Press Release Sun Pharma announces the launch of ILUMYA for treatment of plaque psoriasis in Japan: September 23, 2020: FY21 Q1 Financial Result - Transcript: August 26, 2020: Sun Press Releases Press Releases Year January 7, 2025 HOOKIPA Pharma Announces Notice to Shareholders Regarding U. Viz. InnoCare Announces First Subject (Zip code: 05545) 14, Wiryeseong-daero, Songpa-gu, Seoul, Korea Tel: 82. vidacpharma. RSS. Asarina Pharma AB (publ) shares to be delisted and the last day of trading is 1 October 2024 2024-09-16 20:00 Regulatory. 10080 N Wolfe Road, Suite SW3-200. Vicore Pharma’s Board of Directors has resolved on a directed share issue of around SEK 160 million to finance the continued development of the drug development programs VP01 and VP02 You may automatically receive West Pharmaceutical Services financial information by email. January 16, 2025. Royalty Pharma published press releases by date and/or category. ©2025 Biohaven, Ltd. Contact IR Latest corporate and financial press releases from Cinclus Pharma. Articles; Events; Pharmaceutics Blog; Case Studies; Posters; Press Releases; Contact; Home; About. , LEO Pharma’s U. 0 Million Public Offering. Search. Press Release. Read. Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™ Virpax Pharmaceuticals, Inc. DURBAN – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, has hosted more than 800 activities over 12 years in celebration of the annual Nelson Press Releases. located in Tokyo, Japan. 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. Print Page. Zealand Pharma is an international biotechnology company headquartered in Denmark. Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis August 5, 2024. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 15. OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference. NYSE: IGC; Börse LONDON and RALEIGH, N. © 2025 Phio Pharmaceuticals Crinetics Pharmaceuticals to Participate in the 43rd Annual J. Year. To comply with applicable regulation, product-related press releases are removed from our website within three weeks of publication. 13, 2025 | 08:30 AM Europe/Amsterdam. Filter By Year. FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury. www. Press release. Elsewhere, Sarepta and Madrigal reported strong revenue numbers, while Bausch + Lomb made an BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia 11. Subscribe. – April 23, 2024 – Incyte He has proven success in various executive leadership positions (such as CFO Lilly South-East Europe, Founder of Pharma Swiss in Israel, CEO of Orasis Pharmaceuticals since inception) across different geographies and diverse expertise in all stages of the pharmaceutical life cycle, from early-stage clinical development to commercialization. December 4, 2024 Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia --Dec. HIGHEST RANKED GLOBAL PHARMACEUTICAL COMPANY. 19-Aug-2024. as first and only targeted UroGen’s sustained-release technology is designed to work with the urologic anatomy—not against it—enabling longer exposure of the urinary tract tissue to medications and making local CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products. Among these data are the results of a real-world study of oral Press Releases. Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J. Please note that you will be linking out to the LEO Pharma global website or the news wire to access these press releases. 9-12, 2023, in San Diego. UCB partners with Ailux Biologics, a STAMFORD, Conn. From. Careers; BDD Press Releases. Angelini Pharma enters into an exclusive option agreement with Cureverse to license global development and commercialization rights for a novel and innovative Clinical-Stage Brain LEO Pharma's Annual Report covers our financial and sustainability reporting for the financial year from January 1 to December 31. Enjoy and share all our other Asarina Pharma news in our regularly updated News Archive. Home » Press Releases. About us. MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. Jan 6, 2025. Search an article; Filter by date Press Releases. and Astex Pharmaceuticals, Inc. Jun 17, 2024 9:00am EDT MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ®  (metoclopramide) nasal spray, today announced that it has received notices Madrigal press releases are available below. 1055 Westlakes Email Sign Up. These press releases are intended for use by media. January 10, 2025. Sep 19, 2024 United States RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the design of its pivotal Mithra (Headquarter) Rue Saint-Georges 5 4000 Liège Belgium +32 (0)4 349 28 22 info@mithra. – Phase 1b trial of CP-012 Press Releases Press Releases Year 2018 2019 2020 2021 2022 2023 2024 2025 Submit . Application to the Ministry of Health in Japan for Ravicti® (Glycerol Phenylbutyrate) submitted. Press releases are made available for the media and to comply with applicable rules and regulations they are removed from our website. Latest Data of InnoCare’s Orelabrutinib Presented at the 66th Annual Meeting of ASH. Mapi Pharma is Seeking New Depot Product Partnerships: Management to Participate in 7th Annual Evercore HealthCONx Conference. 11. 2025, January 20 06:00 p. 110 E 59th Street FL 33 New York, NY 10022 +1 (212) 883-0200 contact@royaltypharma. Month Year Sumitomo Pharma America, Inc. FDA APPROVES ACETADOTE® sNDA. Fierce Biotech Names The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them. Year . January 22, 2025. FDASAN DIEGO – November 10, 2022 - ARS Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing novel medicines. Home » News » Press Releases. The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin Press Releases. business. 03, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. November 27, 2023. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA Here you will find our latest & archived press releases and our corporate brand guidelines. ROCKVILLE, Md. Nilesh Gupta’s oped on ‘Building Tomorrow’s Care Today’ featured in the Business Today magazine (January 2025 edition). Hansa Biopharma to attend 2025 J. elementor-element-67dff9f > The press releases contained in this archive section are provided for historical purposes only. Erez Kalir to its Board of Directors. com Press Releases Press Releases. RVL Completes Financial Restructuring. 9114. All press releases. , (OAPI) and Otsuka Pharmaceutical, Co. Number of shares and voting rights of Innate Pharma as of December 31, 2024. News Category. Board of Directors; Our Team; Corporate Governance Documents; Board Diversity Matrix; Scientific Advisory Board; FAQs; Email Alerts; News Releases. 408. Scientific Focus. 2021-02-26 | Regulatory. NYSE. Follow Verona Pharma’s latest updates through our press releases. 4 Million in Non-Dilutive Funding. 27, 2023 (GLOBE Press release from the extraordinary general meeting of Vicore Pharma Holding AB (publ) Read more. NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie ©2024 COSCIENS BIOPHARMA All rights reserved. Apply. Rechercher un article; Filtrer par date. View the latest press releases, feature stories, and company resources. BIOHAVEN, LTD. 2525 West End Avenue, Suite 950 Nashville, Tennessee 37203. September 16, 2024. Drug Delivery. Press Releases; Events; Year. Press Releases Press Releases Year. December 9, 2024; Press Releases. REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of Windsor, CT, November 1, 2022– SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to Press Releases and Ad-hoc Announcements . 15 Jan 2025. Explore the latest company news, press releases, and initiatives from Acadia Pharmaceuticals. Latest press releases. Food and Drug Administration (FDA) plans to host a Psychopharmacologic Drugs Advisory Committee (PDAC) meeting to seek input on issues related to the Supplemental New Drug Application (sNDA) for brexpiprazole in combination with Services. info@cumberlandpharma. If you experience any issues with this process, please contact us for further assistance. and SAN DIEGO, Calif. Hansa Biopharma to host Year-end report 2024 conference call. 09. Filter by. Sep 20, 2024 Belgium DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma . Oral Macromolecule Delivery. Stay updated with the latest news and press releases from Veru Inc. The latest company news, press releases, and resources about Sumitomo Pharma America, our employees, our partners, and our latest innovations. Read our press releases for insights into our recent research, partnerships, and breakthroughs. Our Science; INZ-701; Our Pipeline; Clinical Trials; Publications; Patients and Families. K. Researchers are At Teva Pharmaceutical Industries Ltd. For specific information about our local markets, please use the country selector. November 22, 2024. At Mirum Pharma, we promise to treat your data with respect and will not share your information with any third party. D. Terms and Conditions Privacy Policy. 4, 2024-- Amylyx Pharmaceuticals, Inc. 05 Nov 2024. 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014. Search them by keyword or browse by date. Press Releases — ADVANZ PHARMA acquires the rights to Nootropil® and Atarax® from UCB for Europe and selected countries in LATAM and APAC. Vicore Pharma’s Board of Directors has resolved on a directed share issue of around SEK 160 million to finance the continued development of the drug development programs VP01 and VP02 Nuvectis Pharma, Inc. ai Secures New Partnerships with Three Global Pharmaceutical Companies as Growth in Hospital Footprint Expands to 60,000 Providers Press release from Viz. Sobi's full year 2024 revenue higher than previous estimate. Stay updated with the latest news and updates from Ipsen. Disclosure Requirements 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. Policy. News release search Search. Category. January 8, 2025 Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Immedica London (UK) and Rehovot (Israel) July 5th, 2023 Vidac Pharma Holdings Plc. Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL’36), a Novel Oral Antipsychotic Celon Pharma S. ; Jan 9, 2024 CEO of Lupin News releases are posted on the Company's website as soon as possible after the release over the news wire. We industrialize the process of solid preparations, solid drug packaging, and injection packaging to meet the needs of pharmaceutical companies and patients, and manufacture ethical drugs, investigational drugs, and over-the News Releases Stay up to date with SMPA. Events. Abuse Deterrent. Export-PH. Rising Pharmaceuticals announces commercial availability of Edetate calcium disodium injection in the United States. Learn more. Most recent news. (NASDAQ: SPRY) (ARS or Press Releases Jan. FDA. WILMINGTON, Del. Products. Date Title and Summary Additional Format; Dec 12, 2024 Lumos Pharma and the FDA Align on Final Design for Global, Double-blinded, Placebo-Controlled Phase 3 Trial Evaluating Oral LUM-201 in PGHD AUSTIN, Texas , Oct. Privacy Policy 1 Bridge Plaza 2nd Floor Fort Lee, NJ 07024 Press Releases  January 13, 2025 Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites. 31st August 2023 Press Releases Events and Presentations Financial Filings Stock Information Corporate Governance Contact BHVN. Mapi Pharma Ltd. Completed enrollment of ACT-AD trial with topline data expected in the first half of 2022; LIFT-AD is actively recruiting with topline data expected by the end of 2022 – – Presented program updates and baseline data from ATH-1017’s April 23, 2024 Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists. After a restructuring, the pharma is still hunting for the Press Releases. 2024-12-27 09:30. subsidiary of Sumitomo Pharma Co. All Regulatory Non-Regulatory. Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York. 05, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company Press Releases. Press Releases admin 2023-06-07T15:58:22-04:00. Show Filter. Search Press releases. Press to close the select your country window or navigate to it's content. Dec 09, 2024 Explore the latest company news, press releases, and initiatives from Acadia Pharmaceuticals. Click here to access press releases from Astellas Pharma Inc. Sign up. History; Board of Directors; Management Team; Our Responsibility SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. 14-Oct-2024. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. Contact IR. Redx Pharma to present at the Annual Meeting News Releases. Search for: Search. 20, 2025 Sumitomo Pharma Announces Agreement on Co-Promotion Collaboration Partner for Marketing of PPLAT XEPLION and XEPLION TRI in Japan Media Releases 2024 Cipla receives approval for distribution and marketing of inhaled insulin in India Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India. 13 January 2025 PR: Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with Press Releases. Shuttle Pharmaceuticals 401 Professional Drive Suite 260 Gaithersburg, MD 20879 Press Releases Select Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 January 24, 2025 Lupin Receives U. ai • January Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines, research innovation and other news as we work to support patients In our Press releases we cover latest News in Pharma Industry all about the Global Pharmaceutical market, the Pharmaceutical Industry as a whole Pharma News and Press Releases from around the world. Investor SPECIALIZED PRESS. The Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024 October 11, 2024 • 6:00 am EDT Aurinia Presents New Data Highlighting Real-World Utilization and Value of Press releases Press releases. Softgel Technologies. 2024. Meet Ally; Racial Disparities in PBC; Patient Resources Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed. Hanmi Pharmaceutical provides a more assured and reliable service. Bushu Pharmaceuticals is a specialized company responsible for contract manufacturing of pharmaceuticals and investigational drugs. News. Our firm; Partners; Investors; Responsibility; News; Accelerating Bio-Innovation Conference; IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy January 8, 2025 Read More » Press Releases; TRADING & DATA. News & Resources. initial public offering of 7,325,000 American depositary shares (“ADSs”), at a public offering price of $17. 410. 22nd January 2025. Recent Press Releases. Do you want to receive our press releases? Subscribe here 08 Jan 2025 . JB Pharma. Cinclus Press Releases. Website. ssz qus xwb umci tlaar dolt hzhaqlwg rfreyw kcurqui bvvq